EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.3.1.255 | Atherosclerosis |
27755984 |
miRNA-27b modulates endothelial cell angiogenesis by directly targeting Naa15 in atherogenesis. |
unassigned |
0 |
| 2.3.1.255 | Breast Neoplasms |
10464641 |
Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. |
causal interaction |
3 |
| 2.3.1.255 | Breast Neoplasms |
10464641 |
Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. |
diagnostic usage |
3 |
| 2.3.1.255 | Breast Neoplasms |
10464641 |
Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. |
therapeutic application |
3 |
| 2.3.1.255 | Breast Neoplasms |
10464641 |
Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. |
unassigned |
0 |
| 2.3.1.255 | Carcinogenesis |
18794801 |
Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. |
causal interaction |
2 |
| 2.3.1.255 | Carcinogenesis |
20592467 |
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. |
causal interaction |
1 |
| 2.3.1.255 | Carcinogenesis |
20592467 |
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. |
diagnostic usage |
1 |
| 2.3.1.255 | Carcinogenesis |
20592467 |
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. |
therapeutic application |
1 |
| 2.3.1.255 | Carcinogenesis |
18794801 |
Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. |
ongoing research |
2 |
